uniQure N.V. (QURE)
$21.28-2.56%Close
SELLCRISIS · day 14
Key stats
Short interest · FINRA settlement 2026-09-30
- Market cap
- $1.4B
- Beta
- 0.94
- P/E (TTM)
- -5.27
- Short % float
- 15.42%
- Days to cover
- 1.9
- SI change
- -12.1%
- 1W
- -7.72%
- 1M
- -52.64%
- vs SPY 1W
- -8.14%
- vs SPY 1M
- -54.70%
Industry peers
FMP comparable companies · ranked by market cap
Prediction markets
Kalshi · Polymarket · … linked
Loading markets…
Company news
FAQ
- What is LOPJLB’s current signal on QURE?
- LOPJLB’s latest quantitative signal on uniQure N.V. (QURE) is SELL in a CRISIS regime. Signals are updated daily.
- What market regime is QURE in?
- uniQure N.V. (QURE) is currently classified in the CRISIS HMM market regime on LOPJLB.
- What does uniQure N.V. (QURE) do?
- uniQure N.V. develops treatments for patients suffering from rare and other devastating diseases in the United States. The company offers HEMGENIX that allows people living with hemophilia B to produce factor IX, which can lower the risk of bleeding. Its lead product candidate is AMT-130, a gene therapy candidate, which is in phase I/II clinical study for the treatment of Huntingtonâs disease…